Objective This study investigated the role of oxidative damage and nitric oxide (NO) synthases in the fetal heart using a model of intrauterine growth restriction induced by uteroplacental circulation restriction (UCR).
INTRODUCTION
The 'Barker hypothesis' describes the maladaptive genetic programming induced by insults during fetal development. These anomalous stimuli during intrauterine life may affect cell proliferation, cell differentiation, and gene expression in multiple organs. The brain, [1] [2] [3] heart, 4 liver, 5 and kidney [6] [7] [8] are all affected during intrauterine growth restriction (IUGR). IUGR occurs in approximately 6% of all pregnancies and is linked with environmental conditions that affect maternal health or placental development. Numerous studies have suggested an association between IUGR and adult diseases, such as cardiovascular diseases and hypertension. Recent studies have demonstrated that oxidative stress plays a central role in cardiac reprogramming. Oxidative stress can be generated by several conditions, such as prenatal hypoxia, maternal undernutrition or overnutrition, and excessive glucocorticoid exposure. The offspring of pregnant rats subjected to a hypoxia chamber showed impaired nitric oxide (NO)-dependent relaxation in femoral resistance arteries, increased myocardial contractility with sympathetic dominance, and increased nitrotyrosine production in adulthood. Maternal therapy with antioxidants prevented these effects in fetal and adult offspring, suggesting the participation of oxidative stress. 9 Additionally, chronic hypoxia in pregnant guinea pigs induces the expression of inducible nitric oxide synthase (iNOS) genes in the fetal heart. The excessive generation of NO by iNOS contributes to the formation of peroxynitrite, suggesting the participation of oxidative stress. 10 In contrast, L-arginine, the substrate for NO, has a demonstrated role as an endothelium-derived relaxation factor. 11 One important focus of research has been on understanding the interaction between NO reactive nitrogen species and hypoxia-inducible factor 1-alpha (HIF-1α). HIF/ NO signaling has been implicated in many physiological and pathophysiological processes. High NO levels have been shown to modify HIF-1α (nitrosylate or nitrate) and allow this factor to escape normoxic degradation. 12 Interestingly, HIF-1α
can induce molecules with demonstrated cardioprotective functions, such as iNOS, hemeoxygenase 1 (HO-1), and erythropoietin, which, in turn, alleviate myocardial damage. 13 To evaluate the effect of uteroplacental circulation restriction (UCR) in fetal hearts, we used an experimental rabbit model with features that confer some advantages over other models used to study fetal growth restriction. 14, 15 The aim of this study was to evaluate the expression of genes related to cardioprotection (HIF-1α and HO-1), NO synthesis (iNOS, eNOS, and ARG-2), oxidative stress damage, and general histological structure in hearts derived from control and UCR animals.
MATERIALS AND METHODS

Animals
Pregnant New Zealand white rabbits were maintained as described previously. 7 Rabbit handling and all other procedures were performed in accordance with all applicable regulations and guidelines of the Animal Experimental Ethics approved by the Committee of the Universidad de los Andes. Dams were housed for 1 week in separate rabbit breeding cages before surgery on a reversed 12/12-h light cycle, with free access to water and standard chow (Laboratory Rabbit Diet 5321; Lab Supply, TX, USA). Rabbit fetuses at 25 days of gestation were used to create an experimental group of fetal growth restriction by performing ligature of 40-50% of the uteroplacental vessels. In each pregnant rabbit, the surgeon selected the uterine horn as the site of UCR at the time of insult, and nonrestricted animals were used as the control group. We included seven controls and six UCR animals.
Surgical procedure
Before surgery, 0.9 mg/kg of progesterone was administered intramuscularly to induce tocolysis. A peripheral ear venous catheter was placed, and antibiotic was administered (penicillin G 300 000 UI). Ketamine and xylazine (35 and 5 mg/kg, respectively) were administered intramuscularly for anesthetic induction and maintained with an inhaled mixture of 1-5% isoflurane and 1-1.5 L/min oxygen. An abdominal midline laparotomy was performed for uteroplacental vessel ligation at a proportion of 40-50% to induce severe blood flow restriction. 7 Ligatures were performed with silk sutures (4/0).
After the procedure, the abdomen was closed in two layers with a single silk suture (3/0). Animals were maintained under a warming blanket until they were awake and active, and they received intramuscular meloxicam at 0.4 mg/kg/24 h for 48 h as postoperative analgesia. The animals were then housed, and a health checkup was performed each day.
Sample collection and processing
On day 30 (the gestation period for a rabbit averages at 31.5 days), pups were obtained by cesarean section under similar anesthetic conditions. Only living newborns were selected, weighed, and measured. After these measurements, they were sacrificed by decapitation. The hearts were removed from the fetuses and homogenized with an ULTRA-TURRAX homogenizer in lysis buffer [50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Triton X-100, and protease inhibitor (Complete Mini; Roche Applied Science, Indianapolis, IN, USA) and phosphatase inhibitor cocktails (Phosphatase Inhibitor Cocktails 1 and 2; Sigma, St. Louis MO, USA)]. The homogenized hearts were centrifuged (15 000 g, 10 min), and the samples were frozen at À80°C.
Western blot analysis
Western blot analysis was performed according to standard conditions. 7 After blocking the membranes for 1 h at room temperature, they were incubated with mouse anti-α-Tubulin (Abcam, Cambridge, UK), mouse anti-iNOS (R&D Systems, Minneapolis, USA), mouse anti-eNOS (Cell Signaling, MA, USA), mouse anti-phospho-eNOS (Ser-1177) (Cell Signaling), mouse anti-Arginase-2 (Abcam), and mouse anti-HO-1 (Abcam) antibody overnight at 4°C. After washing with 0.1% Tween-20 in 1× phosphate buffered saline, blots were incubated with Alexa Fluor 750 goat anti-mouse IgG (Life Technologies, CA, USA) antibody (1:15 000 dilution) for 2 h at room temperature. The blots were analyzed using an Infrared Odyssey® imagersCLx (Licor, NE, USA).
Real-time polymerase chain reaction
Total RNA was isolated using the RNeasy mini Kit (Qiagen). The RNA concentration was determined by spectrophotometry (NanoDrop 2000; Thermo Scientific), and RNA integrity was assessed by gel electrophoresis. cDNA was prepared from total RNA (0.5 μg) using a reverse transcription system (Improm II Reverse Transcriptase System; Promega). Real-time Quantitative Reverse Transcriptionpolymerase chain reaction (qRT-PCR) was performed in a thermocycler (RotorGene-Q; Qiagen). The detection system records the number of cycles (Ct), and the Ct values were used to calculate the mRNA abundance using the 18S gene for normalization and the ΔCt equation. The primers used for qRT-PCR were as follows:
6. HIF-1α: F-5
Protein carbonyl analysis
The amount of protein carbonyl was measured using a protein carbonyl colorimetric assay kit (Cayman Chemical Company, MI, USA). The protocol was followed as described by the manufacturer. In brief, whole hearts extracted from fetuses were washed five times with 1 mL of cold phosphate buffered saline and homogenized in 500 μL of cold 50 mM phosphate buffer (EDTA 1 mM, pH 6.7) using an ULTRA-TURRAX homogenizer. Each sample was centrifuged at 10 000 g at 4°C for 5 min, and the supernatant was treated with 1% streptomycin in phosphate 50 mM buffer (pH 7.2) at room temperature for 15 min. Nucleic acids were separated by centrifugation at 6000 g at 4°C for 10 min, and the supernatant was divided into two fractions (sample fraction, S1, and control fraction, C1). Then, 800 μL of 2,4-dinitrophenylhydrazine (DNPH) was added to S1, and 800 μL of 2.5 M HCl was added to C1, and both fractions were incubated for 60 min in the dark at room temperature. One milliliter of 20% TCA was added to each fraction, followed by incubation on ice for 5 min and centrifugation at 10 000 g for 10 min at 4°C. The supernatants were discarded, and pellets were suspended in 1 mL of 10% TCA and incubated on ice for 5 min prior to centrifugation at 10 000 g for 10 min at 4°C. Pellets of each fraction were washed and centrifuged three times in 1 mL of (1:1) ethanol/ethyl acetate mixture at 10 000 g for 10 min at 4°C. After the final wash, protein pellets from the S1 and C1 fractions were suspended in 300 μL of guanidine hydrochloride solution and centrifuged at 10 000 g for 10 min at 4°C. Then, 110 μL of each supernatant fraction was transferred to a 96-well plate and measured at 365 nm in a microplate reader (Infinite M200 Pro; Tecan Systems Inc, CA, USA).
Heart morphology
The entire heart was fixed in 5% buffered formalin, embedded in paraffin, serially sectioned at 3-mm intervals, and stained with hematoxylin-eosin. For us to quantify the gross morphology and cardiac wall thickness, representative sections of the right and left ventricles were used for histologic examination. In each heart, ten measurements were made from the inner endocardium to outer epicardium of the right ventricle, left ventricular, and interventricular septum. Coronary vessel dilatation was studied for intramural coronary arteries by determining the transverse diameter of the vessels using an Olympus DP21 camera and its software. The generated data were averaged to produce a single measurement for each animal. All scorers were blinded to treatments.
Statistical analysis
The variables were analyzed using a 
RESULTS
The fetal mortality rates in the control and UCR groups were approximately 15% and 55%, respectively. We compared the body weight, height, and weight/height index of control and UCR animals, and in the UCR fetuses, we found a significant reduction in fetus body size (30.14 ± 0.88 vs 19.90 ± 1.03, *p = 0.0001) and weight (80.63 ± 0.80 vs 69.22 ± 1.30, *p = 0.0001). This reduction was also observed in the weight/ height ratio (0.37 vs 0.29, *p = 0.0004) ( Figure 1A ). The heart weight was significantly reduced in UCR animals compared with the control group ( Figure 1B , **p = 0.0015). However, the heart weight/body weight ratio was similar in both groups ( Figure 1C ). Histological analysis of the fetal heart showed conserved right (0.93 ± 0.1 mm vs 0.88 ± 0.25 mm; Figure 2 ) and left (1.60 ± 0.39 mm vs 1.50 ± 0.36 mm; Figure 2 ) ventricular thickness. In contrast, in the UCR group, the transverse diameter of the vessels was enlarged (149 ± 10.61 μm vs 230 ± 10.39 μm, *p = 0.001; Figure 2 ). Vascular congestion was also increased (hyperemia: vessel filled with blood) (Figure 2 ). We next evaluated the expression of eNOS in the hearts of control and UCR rabbit fetuses. We observed a downregulation of eNOS mRNA levels ( Figure 3A , *p = 0.0130) but a significant increase in eNOS protein levels Figure 1 Uteroplacental circulation-restricted (UCR) animals showed a reduced body weight, body size, and heart weight but a relatively normal heart/body weight ratio. (A) Body weight, body height, and weight/height index of control and UCR fetuses. (B) Heart weight of control and UCR fetuses. (C) Heart/body weight index (mg/g) of control (n = 6) and UCR fetuses (n = 5) (*p < 0.05) ( Figure 3B , *p = 0.0353) in the hearts of UCR rabbits compared with those of the controls. Interestingly, the expression of the phosphorylated active form of eNOS (p-eNOS-serine-1177) was also significantly increased in the hearts of UCR animals compared with those of controls ( Figure 3C , *p = 0.0495). The p-eNOS/eNOS ratio in the hearts of UCR fetuses was not significantly modified ( Figure 3D ), suggesting that most of the eNOS protein was expressed in its active form. ARG-2 activity has been described as competing for the same substrate of eNOS, thereby decreasing its ability to produce NO. We found no differences in the protein expression of ARG-2 in the hearts of both groups ( Figure 3E and F) .
We evaluated oxidative stress damage in the fetal heart, and we observed a significant increase in protein carbonyl levels in the hearts of UCR fetuses ( Figure 4A , *p = 0.0130). Additionally, we observed a significant induction of iNOS expression (mRNA) in the hearts of UCR fetuses compared with the hearts of the control group (qRT-PCR) ( Figure 4B , *p = 0.0364). However, we could not detect iNOS protein expression using commercially available antibodies in rabbit offspring.
In our experimental IUGR model, we observed a significant induction of HIF-1α (mRNA and protein) in hearts derived from UCR animals ( Figure 4E and F, *p = 0.0342). We also studied HO-1, another cardioprotective protein under the control of HIF-1α. We found a significant induction of HO-1 protein levels ( Figure 4D , *p = 0.0463) without variations in HO-1 mRNA abundance ( Figure 4C , * p = 0.1862), suggesting a cardioprotective response during UCR.
DISCUSSION
Our results showed that fetuses subjected to UCR were small, with reduced heart weights but adequate body weights (Figure 1 ). Histological analysis of fetal hearts showed conserved right and left ventricular thickness but dilated and congestive coronary vessels in UCR fetuses. Previously, using the same animal model, Gratacós described that fetal echocardiography showed a more globular cardiac shape, with a lower right sphericity index but similar wall thickness, in UCR subjects compared with that in controls. Furthermore, the control and UCR groups showed similar ejection fractions, although the UCR group had lower mitral annular peak velocities (S 0 ), suggesting cardiac dysfunction. 16 Using our model of IUGR, we found a similar wall thickness in UCR rabbits as in controls, but we did not test mitral annular peak velocities. In previous studies using the same model, an altered ductus venosus blood flow with increased pulsatility index was observed, suggesting fetal hypoxemic condition. 17 We did not test the hypoxic state in the fetal heart at culling. Interestingly, several authors have described a compensatory mechanism, which results in increased blood flow to vital organs such as the brain, heart, and adrenal gland 7,18 during fetal ischemia. Using our IUGR model, we recently described significant deregulation of NOS (eNOS inactivation and iNOS induction) and damage by oxidative stress in fetal growth restricted rabbits. 8 In the present study, we observed increased eNOS activity in UCR hearts (eNOS phosphorylation in Ser-1177) ( Figure 3C ), suggesting an overexpression of the active form of eNOS as a compensatory response to UCR; this indicates that eNOS is affected differentially by UCR in the kidney and heart. Interestingly, recent studies have shown that endothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels. [19] [20] [21] In our model, we did not find changes in ARG-2 expression in UCR animals ( Figure 3E and F). These data suggest that heart vessels may have increased NO levels because of eNOS induction. Previously, we found increased HIF-1α and NFAT5 in fetal kidneys under UCR. 7 In the fetal heart, NFAT5 did not change in both groups (mRNA and protein levels, data not shown). However, increased HIF-1α expression was observed ( Figure 4E and F) , whose induction could be explained by increased iNOS expression (mRNA) in the hearts of UCR fetuses. Our current work aims to further investigate this hypothesis. Nitrogen species produced by iNOS are important mediators of inflammation and oxidative stress damage produced in the heart. 22 We evaluated the oxidative stress damage in the hearts of fetuses under UCR by measuring the protein carbonyl levels. We found a significant induction of carbonyl levels in the hearts derived from UCR animals ( Figure 4A ). Previously, the induction of HO-1 by HIF-1α has been shown to result in a marked improvement in cardiac function by reducing oxidative stress. 23 In our model, we observed a significant protein induction of HO-1 ( Figure 4D ) in the hearts of UCR animals, suggesting a potentially protective role of HO-1 against ROS, although this was insufficient to prevent the increased protein carbonyl levels. However, further studies are required to elucidate the contribution of HO-1 to prevent oxidative damage in UCR animals. The rabbit model presents some advantages over other animal models. Like humans, rabbits show a significant progression in fetal maturation during pregnancy, whereas in rodents, some maturation steps also occur in postnatal life. Nevertheless, our study also has several limitations, mainly associated with the high mortality rate in the UCR group. This high mortality may have limited our interpretation of the results. However, we studied surviving Figure 3 Hearts of uteroplacental circulation-restricted (UCR) fetuses showed changes in protein expression and phosphorylation. (A) eNOS mRNA levels (qRT-PCR); (B) eNOS protein levels (western blot); (C) phospo-eNOS (Ser-1177) levels (western blot); (D) p-eNOS/eNOS index; (E) ARG-2 mRNA levels (qRT-PCR); and (F) ARG-2 protein levels (western blot) of controls (n = 6) and UCR animals (n = 7) (*p < 0.05) fetuses, suggesting that selective ligature of uteroplacental vessels in the pregnant rabbit is a good model of fetal growth restriction for studying the different clinical manifestations observed in humans under similar conditions, such as fetal mortality, biometric restriction, and alterations in the fetal heart.
In conclusion, the present study demonstrates, for the first time, alterations in NO production enzymes and oxidative stress damage in the hearts of fetuses subjected to UCR. Our study provides important insights into the impact of UCR in the fetal heart. Despite the effort to improve heart perfusion, increased oxidative damage was observed during the final state of fetal uterine gestation.
WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?
• The brain, heart, liver, and kidney are all affected during intrauterine growth restriction.
WHAT DOES THIS STUDY ADD?
• The present study demonstrates, for the first time, alterations in nitric oxide production enzymes and oxidative stress damage in the hearts of fetuses subjected to uteroplacental circulation restriction. Our study provides important insights into the impact of uteroplacental circulation restriction in the fetal heart. Despite the effort to improve heart perfusion, increased oxidative damage was observed during the final state of fetal uterine gestation.
